Gene: CCT6B
Official Full Name: chaperonin containing TCP1 subunit 6Bprovided by HGNC
Gene Summary: This gene encodes a molecular chaperone that is a member of the chaperonin-containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31609 | CCT6B Knockout cell line (HEK293) | Human | CCT6B | 1:3~1:6 | Negative | Online Inquiry |
CCT6B Gene Knockout Cell Lines are specifically engineered cellular models that exhibit complete disruption of the CCT6B gene, a component known to play a significant role in the chaperone-like function and protein folding within the cell's cytoplasm. These cell lines are generated through state-of-the-art CRISPR-Cas9 technology, ensuring precise and reliable gene editing that facilitates the study of gene function, protein interactions, and intricate cellular processes.
The primary function of these knockout cell lines is to serve as invaluable tools for researchers to investigate the physiological and pathological roles of CCT6B. By eliminating the expression of this gene, scientists can elucidate the effects on cellular mechanisms, such as stress responses, cell cycle regulation, and protein homeostasis. This allows for a clearer understanding of the gene’s involvement in various diseases, including certain cancers and neurodegenerative disorders.
In research and clinical settings, CCT6B Gene Knockout Cell Lines hold significant scientific importance. They provide a critical model for drug discovery and therapeutic development, enabling researchers to gauge the efficacy of compounds targeting CCT6B-related pathways. Furthermore, these cell lines can aid in biomarker identification and help in understanding resistance mechanisms in cancer therapies.
Advantages of CCT6B Gene Knockout Cell Lines over alternatives include their high specificity and the ability to recapitulate physiological conditions that are often lost in traditional cell line models. Additionally, their generation through the CRISPR-Cas9 system offers consistent and replicable outcomes, ensuring that researchers obtain reproducible data critical for scientific advancement.
For researchers, clinicians, and industry professionals, the value of CCT6B Gene Knockout Cell Lines extends beyond mere functionality; they are a gateway to novel insights into biological processes and potential therapeutic targets. This product empowers users to deepen their understanding of cellular dynamics, ultimately fostering innovations in treatment strategies.
At [Your Company Name], we specialize in the production of high-quality biological products, ensuring that our offerings, such as the CCT6B Gene Knockout Cell Lines, adhere to the highest standards of scientific reliability and integrity, equipping our users with the tools necessary to drive impactful research and clinical discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.